Fresh Recalls

FDAClass II · Drug · Recall D-0734-2026 · Recalled August 5, 2026

Mycophenolate Mofetil for Injection USP recall — MYLAN PHARMACEUTICALS INC

Agency report date: August 5, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Mycophenolate Mofetil for Injection USP
Company / brand
MYLAN PHARMACEUTICALS
Lot / serial / date codes
Lot #: 3241653, Exp 4/30/2027
Distribution
USA Nationwide
Agency product description and boundaries

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of precipitate

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Mycophenolate Mofetil for Injection USP

3. Open the official notice or contact

Official recall ID
D-0734-2026
Brand
MYLAN PHARMACEUTICALS
Classification
Class II
Units affected
5688 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Morgantown, WV, United States
Firm address
1311 Pineview Dr, N/A, 26505-3276

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 3241653, Exp 4/30/2027
Distribution
USA Nationwide
Firm notified the public via
Letter
FDA event ID
99364
Recall initiated
July 2, 2026
FDA classified
August 4, 2026
FDA report date
August 5, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page